DOTTIKON ES HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233 CHF | +0.65% |
|
+1.75% | +1.75% |
| 2023 | Dottikon ES Posts Lower Fiscal H1 Net Income; Sales Up | MT |
| 2023 | Dottikon ES Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| Sales 2024 * | 357M 391M | Sales 2025 * | 395M 432M | Capitalization | 3.21B 3.51B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 8.05 x |
| Net cash position 2024 * | 335M 366M | Net cash position 2025 * | 579M 634M | EV / Sales 2025 * | 6.66 x |
| P/E ratio 2024 * |
32.5
x | P/E ratio 2025 * |
31.3
x | Employees | 678 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 27.87% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.65% | ||
| 1 week | +1.75% | ||
| Current month | -2.10% | ||
| 1 month | -0.64% | ||
| 3 months | +8.62% | ||
| 6 months | +15.92% | ||
| Current year | +1.75% |
1 week
219.00
234.00
1 month
219.00240.00
Current year
208.50244.00
1 year
190.40269.50
3 years
169.00370.00
5 years
43.10370.00
10 years
18.51370.00
| Managers | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
Marlene Born
DFI | Director of Finance/CFO | 49 | 04-12-31 |
Urs Brändli
CTO | Chief Tech/Sci/R&D Officer | 64 | 89-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
| Director/Board Member | 67 | 11-06-30 | |
Bernhard Urwyler
BRD | Director/Board Member | 66 | 20-07-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 233 | +0.65% | 830 |
| 24-04-23 | 231.5 | +1.54% | 1,574 |
| 24-04-22 | 228 | -1.08% | 1,710 |
| 24-04-19 | 230.5 | +4.06% | 2,782 |
| 24-04-18 | 221.5 | -3.28% | 4,002 |
Delayed Quote Swiss Exchange, April 24, 2024 at 11:31 am EDT
More quotes
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Sector
Pharmaceuticals
Calendar
2024-05-27
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
233
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.75% | 3.5B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- DESN Stock
